Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization

Shunsuke Miyamoto(Osaka Medical and Pharmaceutical University), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Yuhei Kogata(Osaka University of Pharmaceutical Sciences), Sousuke Hashida(Osaka University of Pharmaceutical Sciences), Kohei Taniguchi(Osaka University of Pharmaceutical Sciences), Shinichi Terada(Osaka Medical and Pharmaceutical University), Kensuke Hirosuna(Osaka University of Pharmaceutical Sciences), Ruri Nishie(Osaka Medical and Pharmaceutical University), Hiromi Konishi(Osaka Medical and Pharmaceutical University), Kazumasa Komura(Kawasaki Medical School), Shoko Ueda(Osaka Medical and Pharmaceutical University), Tomohito Tanaka
Cancers
June 16, 2022
10.3390/cancers14122969
Cited by 9

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line
|Journal of Biological Chemistry|1999|174